Advertisement
Canada markets close in 3 hours 42 minutes

  • S&P/TSX

    22,009.46
    +137.50 (+0.63%)
     

  • S&P 500

    5,067.12
    +56.52 (+1.13%)
     

  • DOW

    38,469.66
    +229.68 (+0.60%)
     

  • CAD/USD

    0.7314
    +0.0013 (+0.18%)
     

  • CRUDE OIL

    82.87
    +0.97 (+1.18%)
     

  • Bitcoin CAD

    91,218.54
    +673.33 (+0.74%)
     

  • CMC Crypto 200

    1,430.52
    +15.76 (+1.11%)
     

  • GOLD FUTURES

    2,338.20
    -8.20 (-0.35%)
     

  • RUSSELL 2000

    2,000.54
    +33.07 (+1.68%)
     

  • 10-Yr Bond

    4.5900
    -0.0330 (-0.71%)
     

  • NASDAQ

    15,686.94
    +235.64 (+1.53%)
     

  • VOLATILITY

    16.31
    -0.63 (-3.72%)
     

  • FTSE

    8,044.81
    +20.94 (+0.26%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6834
    -0.0016 (-0.23%)
     
MARKETS LIVE BLOG:

STOCKS EXTEND GAINS AS RESULTS SEASON KICKS INTO HIGH GEAR

Tech-focused investors prepare for fresh wave of earnings highlighted by struggling Tesla

Stocks in play: ESSA Pharma Inc.

Baystreet.ca

Has granted incentive stock options to non – executive members of the Corporation's board of directors to purchase up to an aggregate of 225,000 common shares in the capital of the Corporation. The stock options will vest in 36 equal monthly instalments, with the first instalment vesting on the one-month anniversary of the grant date. The stock options are exercisable on or before October 30, 2029 at the price of $4.67 U.S. per Common share and are granted in accordance with the policies of the TSX Venture Exchange and the terms and conditions of the Corporation's stock option plan. ESSA Pharma Inc. shares V.EPI are trading up $0.11 at $6.16.

READ: The 5 Most Disruptive Tech Stocks Of The Year